Tag
An HIV vaccine developed by La Jolla Institute for Immunology and Scripps Research has shown unprecedented success in generating broadly neutralizing antibodies in primates, with human trials now underway.
The Arc Institute hosted its 3rd Annual Investigator Retreat, featuring talks on genome engineering, generative protein models, computational biology, and deep dives into neurodegeneration, immunology, and metabolism.
OpenAI's GPT-5 Pro helped immunologist Derya Unutmaz solve a three-year-old mystery about how glucose affects T cell specialization by suggesting that deoxyglucose interferes with IL-2 protein construction, leading to increased inflammatory Th17 cells.
Researchers at the University of Cambridge have developed the first entirely AI-designed vaccine, which targets entire virus families and has successfully completed a Phase I human trial showing safety and broad immune response.
Immunologist Derya Unutmaz discusses in the podcast how he used OpenAI's Codex and reasoning models to build complex biological simulation applications (such as flow cytometry analysis tools, T-cell receptor simulators), and looks forward to the future of AI-driven 'virtual cells' and digital twins.